Zeev Shoham

Summary

Affiliation: The Hebrew University
Country: Israel

Publications

  1. ncbi request reprint The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation
    Zeev Shoham
    Department of Obstetrics and Gynecology, Infertility and Reproductive Medicine Unit, Kaplan Medical Center, Rehovot, Israel
    Fertil Steril 77:1170-7. 2002
  2. ncbi request reprint Recombinant human follicle-stimulating hormone: a controversial issue--without controversy
    Zeev Shoham
    Department of Obstetrics and Gynecology, Hadassah Medical School, The Hebrew University, Jerusalem, Israel
    Expert Opin Pharmacother 5:1033-44. 2004
  3. ncbi request reprint Treatment of female infertility with recombinant human luteinising hormone: is there a benefit over other available drugs?
    Zeev Shoham
    Reproductive Medicine and Infertility Unit, Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot 76100, Israel
    Expert Opin Pharmacother 4:1985-94. 2003
  4. ncbi request reprint Tools for making correct decisions regarding hormone therapy. part I: background and drugs
    Zeev Shoham
    Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot, Israel, affiliated with the Hadassah Medical School, The Hebrew University, Jerusalem, Israel
    Fertil Steril 81:1447-57. 2004
  5. doi request reprint Progesterone support in IVF: is evidence-based medicine translated to clinical practice? A worldwide web-based survey
    Edi Vaisbuch
    Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot 76100, Israel
    Reprod Biomed Online 25:139-45. 2012
  6. ncbi request reprint Tools for making correct decisions regarding hormone therapy. Part II. Organ response and clinical applications
    Gideon Kopernik
    Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot, Israel, affiliated with the Hadassah Medical School, The Hebrew University, Jerusalem, Israel
    Fertil Steril 81:1458-77. 2004
  7. ncbi request reprint Ovarian stimulation in polycystic ovarian syndrome
    Yuval Or
    Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot, Israel
    Int Surg 91:S25-30. 2006
  8. ncbi request reprint Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation
    Ernest Loumaye
    Serono International, Reproductive Health Clinical Development Unit, Geneva, Switzerland
    Hum Reprod 18:314-22. 2003

Collaborators

  • David T Baird
  • Edi Vaisbuch
  • Yuval Or
  • Gideon Kopernik
  • Ernest Loumaye
  • Milton Leong
  • Patrick Engrand
  • Stephen G Hillier

Detail Information

Publications8

  1. ncbi request reprint The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation
    Zeev Shoham
    Department of Obstetrics and Gynecology, Infertility and Reproductive Medicine Unit, Kaplan Medical Center, Rehovot, Israel
    Fertil Steril 77:1170-7. 2002
    ..To discuss the clinical therapeutic window for LH during the follicular phase...
  2. ncbi request reprint Recombinant human follicle-stimulating hormone: a controversial issue--without controversy
    Zeev Shoham
    Department of Obstetrics and Gynecology, Hadassah Medical School, The Hebrew University, Jerusalem, Israel
    Expert Opin Pharmacother 5:1033-44. 2004
    ..The purpose of this report is to describe and evaluate recent developments in the use of recombinant human follicle-stimulating hormone...
  3. ncbi request reprint Treatment of female infertility with recombinant human luteinising hormone: is there a benefit over other available drugs?
    Zeev Shoham
    Reproductive Medicine and Infertility Unit, Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot 76100, Israel
    Expert Opin Pharmacother 4:1985-94. 2003
    ....
  4. ncbi request reprint Tools for making correct decisions regarding hormone therapy. part I: background and drugs
    Zeev Shoham
    Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot, Israel, affiliated with the Hadassah Medical School, The Hebrew University, Jerusalem, Israel
    Fertil Steril 81:1447-57. 2004
    ..To review existing scientific data related to the biology of estrogen in the aging process of women, and to understand the pharmacology, physiology, and diversity of sex hormones...
  5. doi request reprint Progesterone support in IVF: is evidence-based medicine translated to clinical practice? A worldwide web-based survey
    Edi Vaisbuch
    Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot 76100, Israel
    Reprod Biomed Online 25:139-45. 2012
    ..Furthermore, although there is no firm evidence to support the continuation of LPS until 10-12 weeks' gestation, this practice is used in the majority of IVF cycles worldwide...
  6. ncbi request reprint Tools for making correct decisions regarding hormone therapy. Part II. Organ response and clinical applications
    Gideon Kopernik
    Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot, Israel, affiliated with the Hadassah Medical School, The Hebrew University, Jerusalem, Israel
    Fertil Steril 81:1458-77. 2004
    ..To review existing scientific knowledge of the complicated and variable behavior and response to hormone therapy (HT) of different organs during aging, and to summarize long-term consequences on human health...
  7. ncbi request reprint Ovarian stimulation in polycystic ovarian syndrome
    Yuval Or
    Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot, Israel
    Int Surg 91:S25-30. 2006
    ..Because PCOS contains a verity of fertility and general health problems and symptoms, it is of great importance to "tailor" the specific treatment to the individual patient...
  8. ncbi request reprint Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation
    Ernest Loumaye
    Serono International, Reproductive Health Clinical Development Unit, Geneva, Switzerland
    Hum Reprod 18:314-22. 2003
    ..The objective of these studies was to test the hypothesis that over-dosing with recombinant human LH (rLH) during the late follicular phase would suppress the development of follicles...